{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Looker O"],"funding":["National Health and Medical Research Council"],"pagination":["442-461"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9543830"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["23(9)"],"pubmed_abstract":["Plasmodium falciparum parasites which cause malaria, traffic hundreds of proteins into the red blood cells (RBCs) they infect. These exported proteins remodel their RBCs enabling host immune evasion through processes such as cytoadherence that greatly assist parasite survival. As resistance to all current antimalarial compounds is rising new compounds need to be identified and those that could inhibit parasite protein secretion and export would both rapidly reduce parasite virulence and ultimately lead to parasite death. To identify compounds that inhibit protein export we used transgenic parasites expressing an exported nanoluciferase reporter to screen the Medicines for Malaria Venture Malaria Box of 400 antimalarial compounds with mostly unknown targets. The most potent inhibitor identi"],"journal":["Traffic (Copenhagen, Denmark)"],"pubmed_title":["The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites."],"pmcid":["PMC9543830"],"funding_grant_id":["119780521","1092789"],"pubmed_authors":["Looker O","Crabb BS","Dans MG","Gilson PR","Bullen HE","Sleebs BE"],"additional_accession":[]},"is_claimable":false,"name":"The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.","description":"Plasmodium falciparum parasites which cause malaria, traffic hundreds of proteins into the red blood cells (RBCs) they infect. These exported proteins remodel their RBCs enabling host immune evasion through processes such as cytoadherence that greatly assist parasite survival. As resistance to all current antimalarial compounds is rising new compounds need to be identified and those that could inhibit parasite protein secretion and export would both rapidly reduce parasite virulence and ultimately lead to parasite death. To identify compounds that inhibit protein export we used transgenic parasites expressing an exported nanoluciferase reporter to screen the Medicines for Malaria Venture Malaria Box of 400 antimalarial compounds with mostly unknown targets. The most potent inhibitor identi","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2025-04-26T22:06:14.446Z","creation":"2025-02-19T01:03:05.078Z"},"accession":"S-EPMC9543830","cross_references":{"pubmed":["36040075"],"doi":["10.1111/tra.12862"]}}